Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 46592-46593 [2013-18492]
Download as PDF
<![CDATA[
46592
Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received within 30 days of this notice.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Children’s Hospital Graduate Medical
Education Payment Program (CHGME
PP) Annual Report; OMB No. 0915–
0313—Extension.
SUMMARY:
Abstract: The CHGME Payment
Program was enacted by Public Law
106–129 to provide federal support for
graduate medical education (GME) to
freestanding children’s hospitals,
similar to Medicare GME support
received by other, non-children’s
hospitals. The legislation indicates that
eligible children’s hospitals will receive
payments for both direct and indirect
medical education. Direct payments are
designed to offset the expenses
associated with operating approved
graduate medical residency training
programs and indirect payments are
designed to compensate hospitals for
expenses associated with the treatment
of more severely ill patients and the
additional costs relating to teaching
residents in such programs.
The CHGME Payment Program statute
Public Law 109–307 requires that
CHGME-participating hospitals provide
information about their residency
training programs in an annual report to
HRSA that will be an addendum to the
hospitals’ annual applications for funds.
Data are required to be collected on
the: (1) Types of training programs that
the hospital provided for residents such
as general pediatrics, internal medicine/
pediatrics, and pediatric subspecialties
including both medical subspecialties
certified and non-medical
subspecialties; (2) the number of
training positions for residents, the
number of such positions recruited to
fill, and the number of positions filled;
(3) the types of training that the hospital
provided for residents related to the
health care needs of different
populations such as children who are
underserved for reasons of family
income or geographic location,
including rural and urban areas; (4)
changes in residency training including
changes in curricula, training
experiences, and types of training
programs, and benefits that have
resulted from such changes and changes
for purposes of training residents in the
measurement and improvement of the
quality and safety of patient care; (5)
and the numbers of residents
(disaggregated by specialty and
subspecialty) who completed training in
the academic year and care for children
within the borders of the service area of
the hospital or within the borders of the
state in which the hospital is located.
Need and Proposed Use of the
Information: The CHGME Payment
Program statute Public Law 109–307
requires that CHGME-participating
hospitals continue to provide
information about their residency
training programs in an annual report to
HRSA that must address statutory
reporting requirements including types
of training, number of training
positions, types of training to care for
underserved children, changes in
residency training, and practice location
of graduates.
Likely Respondents: CHGME Payment
Program participating children’s
hospitals.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
54
1
54
10.4
561.6
54
1
54
74.0
3996.0
Total ..............................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Screening Instrument (HRSA 100–1) ..................................
Annual Report: Hospital and Program Level Information
(HRSA 100–2 and 100–3) ................................................
54
........................
54
84.4
4557.6
VerDate Mar<15>2010
17:02 Jul 31, 2013
Jkt 229001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
E:\FR\FM\01AUN1.SGM
01AUN1
Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices
Dated: July 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–18492 Filed 7–31–13; 8:45 am]
National Eye Institute; Notice of Closed
Meeting
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Molecular and Cellular
Neurobiology.
Date: August 12, 2013.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Peter B Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–18450 Filed 7–31–13; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:02 Jul 31, 2013
Jkt 229001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI K99 Review.
Date: July 31, 2013.
Time: 1:00 p.m. to 1:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Brian Hoshaw, Ph.D.
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 5635
Fishers Lane, Suite 1300, Rockville, MD
20892, 301–451–2020,
hoshawb@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 26, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–18451 Filed 7–31–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-up
Exclusive License: Kits for the
Detection of Human Interferon-Alpha
Subtypes and Allotypes
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR 404, that
SUMMARY:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
46593
the National Institutes of Health (NIH),
Department of Health and Human
Services, is contemplating the grant of a
start-up exclusive license to practice the
inventions embodied in: US provisional
application No. 61/116,563, filed
November 20, 2008, PCT application
No. PCT/US2009/65382, filed November
20, 2009; and corresponding National
Phase filings in the US, EP, AU, CA, IL,
JP and HK (NIH Ref. E–157–2008/0),
titled ‘‘Compositions for Detecting
Human Interferon-Alpha Subtypes and
Methods of Use’’, to IES Diagnostics,
LLC having a place of business at 12
Upper Drive, Watchung, NJ 07069. The
patent rights in these inventions have
been assigned to the United States of
America.
Only written comments and/or
application for a license that are
received by the NIH Office of
Technology Transfer on or before
August 16, 2013 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Cristina Thalhammer-Reyero, Ph.D.,
M.B.A., Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Email:
thalhamc@mail.nih.gov; Telephone:
301–435–4507; Facsimile: 301–402–
0220.
DATES:
The
prospective start-up exclusive license
will be royalty bearing and will comply
with the terms and conditions of 35
U.S.C. 209 and 37 CFR part 404. The
prospective exclusive license may be
granted unless, within fifteen (15) days
from the date of this published Notice,
NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
This technology relates to use of kits
for the detection of human interferonalpha subtypes and allotypes.
The proposed field of exclusivity may
be limited to the commercialization of
the kits for diagnostic and prognostic
uses that are regulated by the FDA or
equivalent agencies in other countries.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 78, Number 148 (Thursday, August 1, 2013)]
[Notices]
[Pages 46592-46593]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18492]
[[Page 46592]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health Resources and Services Administration
(HRSA) has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received within 30 days of this
notice.
ADDRESSES: Submit your comments, including the Information Collection
Request Title, to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Children's Hospital Graduate
Medical Education Payment Program (CHGME PP) Annual Report; OMB No.
0915-0313--Extension.
Abstract: The CHGME Payment Program was enacted by Public Law 106-
129 to provide federal support for graduate medical education (GME) to
freestanding children's hospitals, similar to Medicare GME support
received by other, non-children's hospitals. The legislation indicates
that eligible children's hospitals will receive payments for both
direct and indirect medical education. Direct payments are designed to
offset the expenses associated with operating approved graduate medical
residency training programs and indirect payments are designed to
compensate hospitals for expenses associated with the treatment of more
severely ill patients and the additional costs relating to teaching
residents in such programs.
The CHGME Payment Program statute Public Law 109-307 requires that
CHGME-participating hospitals provide information about their residency
training programs in an annual report to HRSA that will be an addendum
to the hospitals' annual applications for funds.
Data are required to be collected on the: (1) Types of training
programs that the hospital provided for residents such as general
pediatrics, internal medicine/pediatrics, and pediatric subspecialties
including both medical subspecialties certified and non-medical
subspecialties; (2) the number of training positions for residents, the
number of such positions recruited to fill, and the number of positions
filled; (3) the types of training that the hospital provided for
residents related to the health care needs of different populations
such as children who are underserved for reasons of family income or
geographic location, including rural and urban areas; (4) changes in
residency training including changes in curricula, training
experiences, and types of training programs, and benefits that have
resulted from such changes and changes for purposes of training
residents in the measurement and improvement of the quality and safety
of patient care; (5) and the numbers of residents (disaggregated by
specialty and subspecialty) who completed training in the academic year
and care for children within the borders of the service area of the
hospital or within the borders of the state in which the hospital is
located.
Need and Proposed Use of the Information: The CHGME Payment Program
statute Public Law 109-307 requires that CHGME-participating hospitals
continue to provide information about their residency training programs
in an annual report to HRSA that must address statutory reporting
requirements including types of training, number of training positions,
types of training to care for underserved children, changes in
residency training, and practice location of graduates.
Likely Respondents: CHGME Payment Program participating children's
hospitals.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Screening Instrument (HRSA 100- 54 1 54 10.4 561.6
1).............................
Annual Report: Hospital and 54 1 54 74.0 3996.0
Program Level Information (HRSA
100-2 and 100-3)...............
-------------------------------------------------------------------------------
Total....................... 54 .............. 54 84.4 4557.6
----------------------------------------------------------------------------------------------------------------
[[Page 46593]]
Dated: July 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-18492 Filed 7-31-13; 8:45 am]
BILLING CODE 4165-15-P
